Related Experiment Videos
Prevention of hepatitis type B with specific immune serum globulin
Nephron
|January 1, 1976
Summary
Specific immune serum globulin effectively prevented hepatitis B in 12 chronic renal failure patients undergoing maintenance hemodialysis. This study highlights the immune globulin
Area of Science:
- Hepatology
- Immunology
- Nephrology
Background:
- Hepatitis B poses a significant risk to patients with chronic renal failure undergoing hemodialysis.
- Preventive strategies are crucial to mitigate transmission in this vulnerable population.
Purpose of the Study:
- To evaluate the efficacy of specific immune serum globulin in preventing hepatitis B infection.
- To assess the protective role of immune globulin in hemodialysis patients.
Main Methods:
- A cohort of 12 chronic renal failure patients on maintenance hemodialysis received specific immune serum globulin.
- Patients were monitored over a 15-month period.
- Hepatitis B infection was assessed, including AU antigen status.
Main Results:
- Hepatitis B infection was successfully prevented in all 12 patients throughout the 15-month study period.
- The immune globulin demonstrated preventive value regardless of initial AU antigen status.
Conclusions:
- Specific immune serum globulin is a valuable tool for preventing hepatitis B in hemodialysis patients.
- Prophylactic administration of immune globulin can safeguard this high-risk group from hepatitis B.